Radiotherapy in early stage gastrointestinal lymphoma: results of the German GIT-NHL group.
Willich
N A
NA
Department of Radiotherapy, University of Münster, Germany. willich@uni-muenster.de
Reinartz
G
G
Reers
B
B
Hiddemann
W
W
Tiemann
M
M
Parwaresch
R
R
Grothaus-Pinke
B
B
Kocik
J
J
Koch
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D018572:Disease-Free Survival; D004317:Doxorubicin / Q000008:administration & dosage; D005743:Gastrectomy; D005770:Gastrointestinal Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans; D015993:Life Tables; D008197:Lymph Node Excision; D018442:Lymphoma, B-Cell, Marginal Zone / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D011241:Prednisone / Q000008:administration & dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D016019:Survival Analysis; D016896:Treatment Outcome; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone